hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/glaxo-novo-merck-lead-on-access-to-medicines-according-to-new-ranking#c29536

2008 Index outcomes

Author: Access to Medicine Foundation, Published on: 18 June 2008

This web tool enables visitors to click and sort through the outcomes of the 2008 Access to Medicine Index. The tool presents ratings and rankings of the efforts of twenty of the world’s largest pharmaceutical companies to increase universal access to medicine. Companies can be ranked according to their overall performance or according to scores on one of eight ‘main criteria’...[includes link to full 2008 Access to Medicine Index report]

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Bayer Bristol-Myers Squibb Cipla Eli Lilly Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Novo Group Novo Nordisk (part of Novo Group) Pfizer Ranbaxy Laboratories Roche Sanofi Schering-Plough Teva Pharmaceutical Wyeth (part of Pfizer)